This site is intended only for healthcare professionals resident in the Republic of Ireland
The current World Federation of Hemophilia guidelines for the management of haemophilia were developed using a formal evidence and consensus-based methodology that involved multidisciplinary healthcare professionals and well-informed people living with haemophilia.1
In addition to the WFH guidelines, the British Society for Haematology have produced evidence-based guidelines to summarise best practice for the assessment and management of people living with haemophilia.2,3
(meningococcal groups A, C, W-135 and Y conjugate vaccine)
Nimenrix is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y.1
(meningococcal group B vaccine (recombinant, adsorbed))
Trumenba is indicated for active immunisation of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.2
Meningococcal disease refers to any illness caused by the bacterium Neisseria meningitidis.3 There are six common serogroups of bacteria that cause most meningococcal disease worldwide - A, B, C, W, X and Y.4
Legal Category: S1A
Further information is available upon request
Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Adverse events should also be reported to Pfizer Medical Information on 1800 633 363
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.
Copyright © 2023 Pfizer Limited. All rights reserved.
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023